Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

Published:2012-10 Issue: Volume:110 Page:14-22
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Clarke Noel W.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11430.x/fullpdf

Reference74 articles.

1. Heidenreich A Bolla M Joniau S et al EAU Guidelines on Prostate cancer 2011 http://www.uroweb.org/gls/pdf/08_Prostate_Cancer%20September%2022nd%202011.pdf

2. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative endpoints;Tannock;J Clin Oncol,1996

3. TAX 327 Investigators. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Green Metallic Nanoparticles for Cancer Therapy: Evaluation Models and Cancer Applications;Pharmaceutics;2021-10-18

2. Silencing of MALAT1 inhibits migration and invasion by sponging miR‑1‑3p in prostate cancer cells;Molecular Medicine Reports;2019-08-22

3. Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling;Cell Cycle;2018-07-03

4. Prostate Cancer Stem Cells: Research Advances;International Journal of Molecular Sciences;2015-11-17

5. Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients;Cancer;2014-08-08